العودة   منتدى نيو حب > المركز التعليمي لحب جديد > الجامعات العربيه > كلية الصيدلة

FDA advice about phenylpronalamine

كلية الصيدلة

17-10-2007, 11:31 PM
هبة الله
 
FDA advice about phenylpronalamine

Upon the recommendation of the FDA (Food and
Drug Administration), all drugs containing phenylpronalamine should be withdrawn from the U.S. market. This decision was based on a study conducted to investigate the risk of hemorrhagic stroke associated with the use of phenylpronalamine. The study reported an association between phenylpronalamine use and hemorrhagic stroke in women. The increase risk of hemorrhagic stroke was for women using phenylpronalamine for weight control and as a nasal decongestant product. Although the study showed that the risk of hemorrhagic stoke is found mostly in women, men may also be at risk.
The following is a list of all drugs containing phenylpronalamine that are still available and in use in the Egyptian market (for example):
Conta-Flu- Anti-Flu.- Nova-C-M.- Coldact - Flurest - Rhinomol - Michaelon -Noflu -Eskornade - Night and Day Rhinopront -Sinutab
من مواضيع : هبة الله 01-busy_signal_-_pharmacy-(dj_fusion_remix)-2006.mp3
طب الاسنان عند المصريين القدامى
pharmacy.rar
إعلان هام لكل من يرغب فى الإشراف خريجي صيدلة و المعيدين و الدكترة
النباتات الطبية
 

الكلمات الدلالية (Tags)
advice, fda, phenylpronalamine

أدوات الموضوع

الانتقال السريع

FDA advice about phenylpronalamine

الساعة الآن 04:04 AM